Longitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy: A real-world cohort study

医学 蛋白尿 肾功能 泌尿科 回顾性队列研究 队列研究 内科学 肾脏疾病 肾病 蛋白尿 置信区间 肾病科 肾 不利影响 纵向研究 队列 前瞻性队列研究 尿 倾向得分匹配 胃肠病学
作者
Yuhe Yin,Haowen Lin,Qianrong Xiao,Shuman Li,Lixia Xu,Jianchao Ma,Shuangxin Liu,Yiming Tao
出处
期刊:Clinical Nephrology [Dustri-Verlag]
标识
DOI:10.5414/cn112185
摘要

BACKGROUND: Real-world evidence regarding longitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy remains limited. This study evaluated longitudinal changes in proteinuria, kidney function, and safety during Nefecon 16 mg/day treatment in routine clinical practice. MATERIALS AND METHODS: This retrospective cohort study screened 256 patients with IgA nephropathy treated with Nefecon. Patients receiving standard-dose Nefecon 16 mg/day for at least 3 months with available baseline and follow-up efficacy data were included. Only measurements obtained during standard-dose treatment were analyzed. Longitudinal changes in natural logarithm-transformed urine protein-to-creatinine ratio (lnUPCR) and estimated glomerular filtration rate (eGFR) were evaluated using linear mixed-effects models adjusted for age, sex, baseline lnUPCR, baseline eGFR, and time-updated renin-angiotensin system (RAS) inhibitor and sodium-glucose cotransporter 2 (SGLT2) inhibitor use. RESULTS: . Compared with baseline, lnUPCR was significantly lower at 3 months (β = -0.337, 95% confidence interval (CI): -0.483 to -0.191), 6 months (β = -0.426, 95% CI: -0.614 to -0.237), and 9 months (β = -0.451, 95% CI: -0.680 to -0.221; all p < 0.001). Piecewise analysis showed that UPCR declined most rapidly during the first 3 months. eGFR was significantly higher at 3 and 6 months and remained numerically higher at 9 months. Baseline proteinuria significantly modified the lnUPCR trajectory. 32 patients (25.6%) experienced at least 1 adverse event. CONCLUSION: Patients receiving standard-dose Nefecon showed a significant reduction in proteinuria over time, mainly during the first 3 months. Further controlled studies with longer follow-up are needed to determine whether this early reduction is associated with long-term kidney function benefit.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
洁净大树发布了新的文献求助10
1秒前
冻干粉完成签到,获得积分10
2秒前
简单摩托发布了新的文献求助10
2秒前
2秒前
小蘑菇的应助被七听采纳,获得10
2秒前
2秒前
学术文献互助的应助被zz533采纳,获得200
3秒前
刻苦青旋发布了新的文献求助10
3秒前
香蕉觅云的应助被ss采纳,获得10
4秒前
bkagyin的应助被过冷水采纳,获得10
4秒前
忧伤小芒果完成签到,获得积分10
4秒前
4秒前
怡然的伊完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
情怀的应助被sss采纳,获得10
5秒前
Haohahaha完成签到,获得积分10
5秒前
molihuakai的应助被kirito7采纳,获得10
5秒前
领导范儿的应助被周飞跃采纳,获得10
5秒前
5秒前
5秒前
6秒前
SciGPT的应助被Rum9采纳,获得10
6秒前
小祎完成签到,获得积分20
6秒前
等待三德完成签到 ,获得积分10
6秒前
搜集达人的应助被义气的思松采纳,获得10
7秒前
7秒前
清风明月发布了新的文献求助10
8秒前
爱听歌的机器猫完成签到,获得积分10
8秒前
8秒前
Laus发布了新的文献求助10
8秒前
虫儿飞发布了新的文献求助10
8秒前
Zhen Wang完成签到,获得积分10
8秒前
MAKESIME发布了新的文献求助10
9秒前
9秒前
9秒前
9秒前
彩色乐儿完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177464
求助须知:如何正确求助?哪些是违规求助? 9568344
关于积分的说明 21798806
捐赠科研通 7772101
什么是DOI,文献DOI怎么找? 3432346
关于科研通互助平台的介绍 2556593
邀请新用户注册赠送积分活动 2477882